Want to see DE:SHL full AI Analyst Report?

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

125 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHL Analyst Ratings

Moderate Buy

6 Buy

5 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Siemens

Healthineers AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€44.09

▲(25.76% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €44.09 with a high forecast of €54.30 and a low forecast of €37.00. The average price target represents a 25.76% change from the last price of €35.06.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"33":"€33","44":"€44","55":"€55","38.5":"€38.5","49.5":"€49.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€54.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.09090909090909,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€44.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€37.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[33,38.5,44,49.5,55],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.86,38.20153846153846,39.543076923076924,40.88461538461539,42.22615384615384,43.567692307692305,44.90923076923077,46.25076923076923,47.59230769230769,48.93384615384615,50.27538461538461,51.61692307692307,52.958461538461535,{"y":54.3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.86,37.416223776223774,37.972447552447555,38.52867132867133,39.084895104895104,39.641118881118885,40.19734265734266,40.753566433566434,41.30979020979021,41.86601398601399,42.42223776223776,42.978461538461545,43.53468531468532,{"y":44.09090909090909,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.86,36.87076923076923,36.88153846153846,36.89230769230769,36.903076923076924,36.91384615384615,36.924615384615386,36.93538461538461,36.94615384615385,36.956923076923076,36.96769230769231,36.97846153846154,36.98923076923077,{"y":37,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.213,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.429,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.59,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.865,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.346,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.37,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.39,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.88,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.26,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.48,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.86,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€54.30

Average Price Target€44.09

Lowest Price Target€37.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Natalia Webster

RBC Capital

€45

Buy

28.35%

Upside

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Siemens Healthineers AG (SEMHF)

Sam England

Berenberg Bank

€39

Hold

11.24%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (Other OTC: SEMHF), Neurocrine (NASDAQ: NBIX) and Karyopharm Therapeutics (NASDAQ: KPTI)

Susannah Ludwig

Bernstein

€45.7

Buy

30.35%

Upside

Reiterated

07/31/26

Bernstein Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)

Julien Dormois

Jefferies

€50

Buy

42.61%

Upside

Reiterated

07/31/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Illumina (NASDAQ: ILMN) and Siemens Healthineers AG (Other OTC: SEMHF)

David Adlington

J.P. Morgan

€54.3

Buy

54.88%

Upside

Reiterated

07/31/26

J.P. Morgan Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Kavya Deshpande

UBS

€38

Hold

8.39%

Upside

Reiterated

07/14/26

UBS Sticks to Its Hold Rating for Siemens Healthineers AG (SEMHF)

Falko Friedrichs

Deutsche Bank

€38

Hold

8.39%

Upside

Reiterated

07/06/26

Deutsche Bank Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)

Aisyah Noor

Morgan Stanley

€41→€37

Hold

5.53%

Upside

Reiterated

06/23/26

Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley

Hassan Al-Wakeel

Barclays

€50

Buy

42.61%

Upside

Reiterated

05/22/26

Barclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)

Richard Felton

Goldman Sachs

€45→€42

Hold

19.79%

Upside

Reiterated

05/11/26

Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)

Oliver Reinberg

Kepler Capital

€49→€46

Buy

31.20%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)

Veronika Dubajova

Citi

€59→€53

Buy

51.17%

Upside

Reiterated

04/22/26

Siemens Healthineers price target lowered to EUR 53 from EUR 59 at CitiSiemens Healthineers price target lowered to EUR 53 from EUR 59 at Citi

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

03/09/26

DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Nico Chen

DBS

€52

Buy

48.32%

Upside

Reiterated

02/24/26

DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€48

Hold

36.91%

Upside

Downgraded

12/10/25

Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Natalia Webster

RBC Capital

€45

Buy

28.35%

Upside

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Siemens Healthineers AG (SEMHF)

Sam England

Berenberg Bank

€39

Hold

11.24%

Upside

Reiterated

07/31/26

Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (Other OTC: SEMHF), Neurocrine (NASDAQ: NBIX) and Karyopharm Therapeutics (NASDAQ: KPTI)

Susannah Ludwig

Bernstein

€45.7

Buy

30.35%

Upside

Reiterated

07/31/26

Bernstein Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)

Julien Dormois

Jefferies

€50

Buy

42.61%

Upside

Reiterated

07/31/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Illumina (NASDAQ: ILMN) and Siemens Healthineers AG (Other OTC: SEMHF)

David Adlington

J.P. Morgan

€54.3

Buy

54.88%

Upside

Reiterated

07/31/26

J.P. Morgan Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Kavya Deshpande

UBS

€38

Hold

8.39%

Upside

Reiterated

07/14/26

UBS Sticks to Its Hold Rating for Siemens Healthineers AG (SEMHF)

Falko Friedrichs

Deutsche Bank

€38

Hold

8.39%

Upside

Reiterated

07/06/26

Deutsche Bank Reaffirms Their Hold Rating on Siemens Healthineers AG (SEMHF)

Aisyah Noor

Morgan Stanley

€41→€37

Hold

5.53%

Upside

Reiterated

06/23/26

Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley

Hassan Al-Wakeel

Barclays

€50

Buy

42.61%

Upside

Reiterated

05/22/26

Barclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)

Richard Felton

Goldman Sachs

€45→€42

Hold

19.79%

Upside

Reiterated

05/11/26

Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)

Oliver Reinberg

Kepler Capital

€49→€46

Buy

31.20%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)

Veronika Dubajova

Citi

€59→€53

Buy

51.17%

Upside

Reiterated

04/22/26

Siemens Healthineers price target lowered to EUR 53 from EUR 59 at CitiSiemens Healthineers price target lowered to EUR 53 from EUR 59 at Citi

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

03/09/26

DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Nico Chen

DBS

€52

Buy

48.32%

Upside

Reiterated

02/24/26

DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€48

Hold

36.91%

Upside

Downgraded

12/10/25

Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months

Hassan Al-WakeelBarclays

Success Rate

15/35 ratings generated profit

Average Return

-0.92%

Copying Hassan Al-Wakeel's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -0.92% per trade.

1 Year

Hassan Al-WakeelBarclays

Success Rate

13/35 ratings generated profit

Average Return

-2.90%

Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 37.14% of your transactions generating a profit, with an average return of -2.90% per trade.

2 Years

David AdlingtonJ.P. Morgan

Success Rate

23/60 ratings generated profit

Average Return

-8.65%

Copying David Adlington's trades and holding each position for 2 Years would result in 38.33% of your transactions generating a profit, with an average return of -8.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHL has received 7 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 44.09.

Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.68 with a range of €0.65 to €0.70. The previous quarter’s EPS was €0.70. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €6.86B with a range of €6.58B to €7.09B. The previous quarter’s sales results were €5.76B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?

Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 44.09.

What is DE:SHL’s upside potential, based on the analysts’ average price target?

Siemens Healthineers AG has 25.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Siemens Healthineers AG a Buy, Sell or Hold?

Siemens Healthineers AG has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.

What is Siemens Healthineers AG’s share price target?

The average share price target for Siemens Healthineers AG is 44.09. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €54.30 ,and the lowest forecast is €37.00. The average share price target represents 25.76% Increase from the current price of €35.06.

What do analysts say about Siemens Healthineers AG?

Siemens Healthineers AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Siemens Healthineers AG?

To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

SHL Analyst Ratings

SHL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Siemens Healthineers AG

SHL Analyst Recommendation Trends

SHL Financial Forecast

SHL Earnings Forecast

SHL Sales Forecast

SHL Stock Forecast FAQ

Detailed List of Analyst Forecasts